טוען...
Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia
The 2013 American College of Cardiology/American Heart Association guidelines on cholesterol management placed greater emphasis on statin therapy given the well-established benefits in primary and secondary prevention of cardiovascular disease. Residual risk may remain after statin initiation, in pa...
שמור ב:
| הוצא לאור ב: | Vasc Health Risk Manag |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5161399/ https://ncbi.nlm.nih.gov/pubmed/28003756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S58149 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|